{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:52:08Z","timestamp":1793919128684,"version":"4.8.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82170834\uff0cNo. U22A20286, and No. 82300911"],"award-info":[{"award-number":["No. 82170834\uff0cNo. U22A20286, and No. 82300911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"crossref","award":["2024ZD0531901"],"award-info":[{"award-number":["2024ZD0531901"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Office of Science Technology and Talent Work of Luzhou","award":["No. 2025JBH003"],"award-info":[{"award-number":["No. 2025JBH003"]}]},{"name":"Sichuan Science and Technology Program","award":["No. 2024YFFK0081"],"award-info":[{"award-number":["No. 2024YFFK0081"]}]},{"name":"the Project of Southwest Medical University","award":["No. 2024LCYXZX12"],"award-info":[{"award-number":["No. 2024LCYXZX12"]}]},{"name":"the Health Commission of Sichuan Province Medical Science and Technology Program","award":["NO. 24CXTD02"],"award-info":[{"award-number":["NO. 24CXTD02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04987-x","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:25:04Z","timestamp":1776151504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Finerenone in IgA nephropathy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"27","author":[{"given":"Jidi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"5","key":"4987_CR1","doi-asserted-by":"publisher","first-page":"151564","DOI":"10.1016\/j.semnephrol.2025.151564","volume":"44","author":"M Ghaddar","year":"2024","unstructured":"Ghaddar M, Canney M, Barbour SJ. IgA Nephropathy: Epidemiology and Disease Risk Across the World [J]. Semin Nephrol. 2024;44(5):151564.","journal-title":"Semin Nephrol"},{"issue":"3","key":"4987_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2021.01.024","volume":"78","author":"P Pattrapornpisut","year":"2021","unstructured":"Pattrapornpisut P, Avila-Casado C, Reich HN. IgA Nephropathy: Core Curriculum 2021 [J]. Am J Kidney Dis. 2021;78(3):429\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4987_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases [J]. Kidney Int. 2021;100(4):S1\u2013276.","journal-title":"Kidney Int"},{"issue":"2","key":"4987_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ekir.2023.11.026","volume":"9","author":"H Selvaskandan","year":"2024","unstructured":"Selvaskandan H, Barratt J, Cheung CK. Novel Treatment Paradigms: Primary IgA Nephropathy [J]. Kidney Int Rep. 2024;9(2):203\u201313.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"4987_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/07853890.2023.2171110","volume":"55","author":"JR Gonz\u00e1lez-Juanatey","year":"2023","unstructured":"Gonz\u00e1lez-Juanatey JR, G\u00f3rriz JL, Ortiz A, et al. Cardiorenal benefits of finerenone: protecting kidney and heart [J]. Ann Med. 2023;55(1):502\u201313.","journal-title":"Ann Med"},{"issue":"23","key":"4987_CR6","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J]. N Engl J Med. 2020;383(23):2219\u201329.","journal-title":"N Engl J Med"},{"issue":"24","key":"4987_CR7","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes [J]. N Engl J Med. 2021;385(24):2252\u201363.","journal-title":"N Engl J Med"},{"issue":"8","key":"4987_CR8","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s40620-024-02070-y","volume":"37","author":"SB Nicholas","year":"2024","unstructured":"Nicholas SB, Correa-Rotter R, Desai NR, et al. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting [J]. J Nephrol. 2024;37(8):2223\u201332.","journal-title":"J Nephrol"},{"issue":"6","key":"4987_CR9","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","volume":"93","author":"J Barrera-Chimal","year":"2018","unstructured":"Barrera-Chimal J, Estrela GR, Lechner SM, et al. The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling [J]. Kidney Int. 2018;93(6):1344\u201355.","journal-title":"Kidney Int"},{"issue":"5","key":"4987_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","volume":"43","author":"NR Medjeral-Thomas","year":"2021","unstructured":"Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy [J]. Semin Immunopathol. 2021;43(5):679\u201390.","journal-title":"Semin Immunopathol"},{"issue":"9","key":"4987_CR11","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1681\/ASN.2004111006","volume":"16","author":"IC Moura","year":"2005","unstructured":"Moura IC, Arcos-Fajardo M, Gdoura A, et al. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy [J]. J Am Soc Nephrology: JASN. 2005;16(9):2667\u201376.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"3","key":"4987_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/01.ASN.0000115401.07980.0C","volume":"15","author":"IC Moura","year":"2004","unstructured":"Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy [J]. J Am Soc Nephrology: JASN. 2004;15(3):622\u201334.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"4987_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","volume":"209","author":"L Berthelot","year":"2012","unstructured":"Berthelot L, Papista C, Maciel TT, et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors [J]. J Exp Med. 2012;209(4):793\u2013806.","journal-title":"J Exp Med"},{"key":"4987_CR14","doi-asserted-by":"publisher","first-page":"100251","DOI":"10.1016\/j.metop.2023.100251","volume":"19","author":"A Mima","year":"2023","unstructured":"Mima A, Lee R, Murakami A, et al. Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL\/min\/1.73 m2 [J]. Metabolism OPEN. 2023;19:100251.","journal-title":"Metabolism OPEN"},{"key":"4987_CR15","doi-asserted-by":"publisher","first-page":"100294","DOI":"10.1016\/j.metop.2024.100294","volume":"22","author":"A Mima","year":"2024","unstructured":"Mima A, Saito Y, Matsumoto K, et al. Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease [J]. Metabolism OPEN. 2024;22:100294.","journal-title":"Metabolism OPEN"},{"issue":"1","key":"4987_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000546536","volume":"11","author":"Y Ouyang","year":"2025","unstructured":"Ouyang Y, Weng Q, Zhu X, et al. Finerenone in Primary IgA Nephropathy: A Matched Case-Control Study [J]. Kidney Dis. 2025;11(1):440\u20139.","journal-title":"Kidney Dis"},{"key":"4987_CR17","doi-asserted-by":"publisher","first-page":"9755","DOI":"10.2147\/JIR.S531236","volume":"18","author":"Y Guo","year":"2025","unstructured":"Guo Y, Zhang X, Zhao S, et al. Effect and Safety of Finerenone in Patients with IgA Nephropathy [J]. J Inflamm Res. 2025;18:9755\u201365.","journal-title":"J Inflamm Res"},{"key":"4987_CR18","unstructured":"Guo Y, Zhao S, Dong Y, Nephrology, et al. Dialysis, transplantation: official publication of the European dialysis and transplant association - European Renal Association, 2025:gfaf244."},{"issue":"5","key":"4987_CR19","doi-asserted-by":"publisher","first-page":"sfaf125","DOI":"10.1093\/ckj\/sfaf125","volume":"18","author":"QR Wang","year":"2025","unstructured":"Wang QR, Wu L, Huang J, et al. Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study [J]. Clin Kidney J. 2025;18(5):sfaf125.","journal-title":"Clin Kidney J"},{"key":"4987_CR20","doi-asserted-by":"crossref","unstructured":"Yu K, Li D, Fan X, et al. Effectiveness and safety of finerenone in IgA nephropathy patients [J]. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association - European Renal Association, 2025: gfaf240.","DOI":"10.1093\/ndt\/gfaf240"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04987-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:33:18Z","timestamp":1779759198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4987"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04987-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"334"}}